CONGENITAL CENTRAL hypothyroidism is a rare endocrine disorder of both man and animals resulting from a deficiency of,
or end-organ resistance to, thyrotro-pin (TSH) or thyrotropin releasing hormone (TRH) at birth. Because thyroid hormone
secretion is essential for normal postnatal development of the nervous and skeletal systems, congenital hypothyroidism is
characterized by disproportionate dwarfism, central and peripheral nervous system abnormalities, and mental deficiency.
In addition, many of the signs of adult-onset hypothyroidism, such as lethargy, unappetence, constipation, dermatopathy,
and hypothermia may be observed.
Although hypothyroidism is often observed in human infants, TSH deficiency is an uncommon cause of congenital thyroid
disease. Only 3.6% of the total cases of canine hypothyroidism occur in dogs younger than 1 year of age, and even fewer
are the result of pituitary or hypothalmic disease. If TSH deficiency does occur, it is often associated with
panhypopituitarism secondary to cystic Rathke's pouch. Congenital isolated TSH deficiency is extrememly rare and
has never been reported in the dog.
The purpose of this study was to report the clinicopathologic features of congenital hypothyroid dwarfism in a family
of Giant Schnauzers, In two of the five dogs, it was documented that the hypothyroidism was central in origin and
appeared to result from isolated TSH deficiency.
MATERIALS AND METHODS
DOGS -
Five related Giant Schnauzer puppies were studied. Three dogs (dogs 1-3) were presented to the
Small Animal Medicine service at the University of California, Davis, and two dogs (dogs 4 and 5)
were presented to the Small Animal Clinic at Texas A & M University for evaluation of dwarfism.
Clinical Evaluation and laboratory Testing
All dogs were evaluated by physical examination, serum biochemical analysis, complete blood counts,
urinalysis, fecal examination for parasites, and skeletal radiographs. Thyroid function was evaluated
in all five dogs by TSH response testing, in four dogs by radioisotopic (pertechenate) imaging and, in two
dogs, by thyroid biopsy.
In two dogs, provocative testing of the pituitary reserves was attempted. A xylazine response test was
performed using 100% pg/kg xylazine IV; blood samples were collected at 0, 15, 30, 45, 60, and 90 minutes
following injection. Growth hormone reserve was also measured following the administration of GHRH (1 pg/kg IV);
blood samples were collected at 0, 15, 30, 45, 60, and 90 minutes following injection. To assess gonadotropin
reserve, GnRH (20 pg/kg, IV) was used. Samples were drawn at 0, 15, 30, 45, 60, and 90 minutes following injection.
A corticotropin releasing hormone (CRH) test was performed using 1 pg/kg CRH IV; Samples were drawn at 0, 15, 30,
45, 60, and 90 minutes following injection. Finally to assess pituitary reserves of TSH, a TRH response test was
performed as previously described. After injection off 100 pg/kg TRH IV, blood samples were collected at
0, 60, 120, 180, 240, 360 and 480 minutes.
Endocrine Testing
Serum triiodothyronine (T3) and thyroxine (T4) were measured using commercial radioimmunoassay (RIA) kits
(NML Tri-Tab T3 and Tetra-Tab T4 RIA kits, Organon Teknika Corporation, Durham, NC). Assays of serial dilutions
of a canine serum pool containing high concentrations of thyroid hormones resulted in inhibition curves with slopes
parrallel to those of the standard curves for T3 and T4. When varying quantities of T4 and T3 were added to a
canine serum pool containing undetectable concentrations of thyroid hormones (to determine the accuracy of the
assays) correlation coefficients of 0.99 were calculated using linear regression analysis for both the T4 and
T3 assays. Sensitivity of the T3 and T4 assays were 0.1 nmol/L and 5 nmol/L, respectively. The intra-assay
coefficient of variation was 3.8%. The interassay coefficients of variation were 7.1% and 3.7% for T4 and T3,
respectively.
Radioimmunoassays of somatotropin (GH), adrenocorticotropin releasing hormone (ACTH), luteinizing hormone (LH), testosterone, progesterone, and estradiol-17B were performed as previously described.
Serum cortisol concentrations were measured using a commercial radioimmunoassay kit (Radioassay Systems labratories,
Ins., 'Carson, CA). Assays of serial dilutions of a canine serum pool containing high concentrations of cortisol
resulted in inhibition curves with slopes parallel to those of the standard curve. The intra-assay and interassay
coefficients of variation were 1.3% and 2.25%, respectively
Results
Historical Findings -
Five Giant Schnauzers, two males and three females less than 1 year of age, were studied. Affected puppies,
although largest at birth, began to show signs of abnormal growth by 3 weeks of age, and all puppies lagged
behind normal littermates after 8 weeks of age. Affected puppies were dwarfed (n=5), lethargic(n=5), somnolent
(N=5) and slow to learn compared with normal littermates (n=5). Other historical findings included abdominal
distension (n=5), constipation (n=3), hoarse vocalizations (n=2), aggressive (n=1), and gait abnormalities (n=5).
PHYSICAL EXAMINATION
All affected puppies were 12-16 weeks of age at examination and weighed 6-9 kg; the normal littermates weighed 10-18 kg. Characteristic physical examination findings were included disporportionate dwarfism (n=5), hyporeflexia (n=5), coarse hair coat (n=3), hypothermia (n=3), shortened pinnae (n=3), and ataxia (n=2). Affected puppies exhibited the characteristic block-like trunk, short malformed limbs, and large head of disporportionate dwarfs. The puppies had severe
abdominal distension and exhibited short stature compared with the normal littermates. In most puppies, the head was
short and broad; macroglossia was evident. Neurologic abnormalities, including hypermetria, hyporeflexia, weakness,
and somnolence, were mild. The hair coat was coarse and rough in all puppies when compared with the normal littermates.
In three puppies, delayed dental eruption of deciduous teeth resulted in abnormalities of adult dentition.
Hematologic abnormalities were limited to mild normocytic normochronic anemia in three of the five puppies.
Serum concentrations of cholesterol (range, 7.96-13.32; normal 3.36-6.46 mmol/L), and serum alkaline phosphate
(range 159-308; normal, 10-90 IH/L) were moderately increased in four of the five puppies. Serum calcium was
mildly increased in two of the five puppies (range, 2.89-3.04; normal, 2.37-2.87 mmol/L). In one puppy,
abdominocentesis showed the presence of a transudative abdominal effusion (clear fluid, 590 WBC/p!, 1210 RBC/p1,
0.9 g/dl protein, 1.012 specific gravity).
RADIOGRAPHIC FINDINGS
All puppies exhibited epiphyseal dysgenesis and delayed epiphyseal maturation characteristic of congenital
hypothyroid dwarfism. Compared with a normal littermate, the forelimb of the affected puppy exhibits virtually
no epiphyseal ossification. The long bones and vertebral bodies and the appendicular diaphyses were reduced in
length prior to treatment. Following treatment, two dogs developed clinical evidence of osteoarthritis in most
proximal and some distal joints. In dog 3, deformity and periarticular osteophyte formation were evident
bilaterally in the scapulohumeral, humeroulnar and humeroradial, coxofemoral, and femorotibial joints.,/font>
THYROID SCANS
Baseline thyroid scans were done on 4 of the 5 puppies (dogs 1,2,4 and 5). Prior to the administration of TSH,
thyroid pertechnetate imaging showed an absence of radioisotope uptake. However, in two puppies (dogs 4 and 5),
TSH, administration for 3 days (5 units SQ, SID) resulted in normal uptake of pertechnetate by the thyroid gland.
Thyroid gland size and shape appeared normal.
Thyroid Biopsy -
Thyroid biopsy was done on two dogs (dogs 4 and 5). During surgery, the thyroid gland appeared normal in size
and shape; a small wedge biopsy was obtained for histological evaluation. Histological evaluation showed areas
of follicular inactivity as evidenced by distension of the follicles with colloid, flattening of the lining epithelial
cells, and decreased numbers of resorption vacuoles.
Thyroid Hormone Assays
Results of thyroid function testing are shown in Table 1. On admission, a TSH response was performed on all dogs. Basal serum thyroxine and triiodothyronine concentrations were low; and the thyroid hormone response following TSH administration was below reference values.
To investigate the possibility of central hypothyroidsim in two of these puppies (dogs 4 and 5), TSH was administered daily at a dosage of 5 units/dog subcutaneously. The TSH response test was repeated after three days. Results of the second TSH response test are also shown in Table 1. Basal serum thyroxine and triiodothytonine concentrations were normal, and following the administration of TSH, thyroid hormone concentrations increased to levels slightly above reference values.
Adrenal and Glandular Function
Results of ACTH response tests, performed on all five dogs, were normal. Basal testosterone, estradiol-17B,
and progesterone concentrations were normal in two puppies tested (dogs and 5).
Pituitary Function
Several pituitary hormones were assessed by provocative testing in two of the dogs (dogs 4 and 5).
The growth hormone (GH) response to xylazine administratiion was assessed prior to and after thyroxine treatment.
As shown in Table 2, the initial test showed normal basal serum GH concentrations but a subnormal response to
provocative stimulation. Following 2 years of therapy with levothyroxine (20 pg/kg), basal GH concentrations were
low in both dogs (dogs 4 and 5) and the GH response to either xylazine or growth hormone releasing hormone (GHRH)
remained subnormal (Table 2). Nevertheless, the dogs have shown no clinical signs of growth hormone deficiency.
An endogenous ACTH and LH response to hypothalamic releasing factors (CRH and GnRH, respectively) showed normal
pituitary reserves of ACTH and LH. As shown in Table 2, the thyroxine response to TRH was virtually nonexistent;
post-stimulation values were less than or equal to basal thyroxine concentrations.
Pedigree Analysis
As shown by the pedigree analysis in Figure 6, all affected individuals can be traced back to the original ancestors on both sides (maternal and paternal). Furthermore, many of the parents and relatives of the affected puppies have been examined and found to be clinically normal (i.e. not dwarfed). A ration of approximately one affected to six nonaffected individuals (5 affected puppies in a total of 29) was observed in this study.
Discussion
Congenital hypothyroidism, which occurs in approximately 1 in 4,000 births, is a relatively common endocrine disorder of human infants. In contrast, reports of congenital hypothyroidism in dogs are relatively few. Congenital hypothyroidism may be caused by aplasia or hypoplasia of the thyroid gland, thyroid ectopia, dyshormonogenesis, maternal goitrogen ingestion, maternal radioactive iodine treatment, iodine deficiency (endemic goiter), autoimmune thyroiditis, hypopituitarism, isolated thyrotropin deficiency, hypothalamic disease, or isolated TRH deficiency. Of these causes of congenital hypothyroidism in children, only 15% are the result of hypothalamic-pituitary disease. In the dog, congenital or developmental thyrotropin deficiency is usually associated with cystic Rathke's pouch. Neither isolated TSH nor TRH deficiency have been well documented as a cause of central hypothyroidism in dogs.
Congenital hypothyroidism, regardless of cause,results in characteristic clinicopathological features. Both dogs and infants have a history of large prolonged gestation) which is followed by aberrant and delayed growth. In the present study, the first signs of abnormal growth occured as early as 3 weeks after birth. Affected puppies could be distinguished from normal littermates by shortened pinnae, abdominal distenstion, and behavioral abnormalities. abnormal body proportions were evident by 8 weeks of age. This is similar to human infants who are normal at birth, but, if undiagnosed, exhibit characteristic signs by 6-8 weeks of age. Other historical findings in these pupies including lethargy, mental dulness, weak nursing. Delayed dental eruption, and abdominal distension are also observed in hypothytoid children.
Physical features of hypothyroid dwarfism in children include hypotonia, umbilical hernia, skin mottling, large anterior and posterior fontanels, macroglossia, hoarse cry, distended abdomen, dry skin, jaundice, palor, slow deep tendon reflex, delayed dental eruption, and hypothermia. In the dogs described in this report, hypotonia, macroglossia, distended abdomen, dry skin, delayed dental eruption, and hypothermia were identified. In addition, because dogs develop more rapidly and become weight bearing sooner than human infants, gait
abnormalities and disproportionate dwarfism were prominent features of hypothyroidism in this study. Midface hypoplasia, broad nose, and a large protruding tongue are some of the sequelae of untreated hypothyroidism in humans. Similar facial features, such as broad maxillas and macroglossia, were observed in affected puppies. In humans, delayed eruption of permanent teeth is observed in untreated congenitally hypothyroid individuals, delayed dental eruption was observed in all dogs but was much more noticeable in the dog (dog 3) treated after 4 months of age. Although abdominal distension was observed in all affected puppies, effusion was evident in only one puppy. In humans, both macroglossia and effusions of the body cavities are the result of myxedematous fluid accumulation. Coarse hair coats were observed in several affected puppies. Similarly, congenitally hypothyroid rats exhibit alterations in hair shaft morphology as a result of thyroid hormone deficiency during development.
Thyroid hormone crucial for proper postnatal development of the nervous system. As a result, a significant number of properly treated and all untreated hypothyroid infants exhibit poor coordination and speech impediments later in life. Delayed treatment often results in low perceptual-motor, visual-spatial, and language scores in children with congenital hypothyroidism. If treatment is delayed beyond 4-6 months, intelligence is irreversibly affected and mental retardation may ensue. Because the bulk of cerebellar development occurs postnatally, Purkinje cell growth is also significantly affected by congenital hypothyroidism. In humans, if treatment is delayed, signs of cerebellar dysfunction, such as ataxia, are observed. In one dog (dog 4), hypermetria has persisted despite treatment of hypothyroidism at 4 months of age.
Skeletal abnormalities are the hallmark of congenital hypothyroidism. Delayed maturation and epiphyseal dygenesis are both recognized features of congenital hythyroidism. Delayed epiphyseal maturation was observed in the vertebral bodies and long bones of affected puppies. Epiphyseal dygenesis, which is characterized by a ragged epiphysis with scattered foci of calcification, is observed in both humans and dogs with untreated congenital hypothyroidism. Normal epiphyseal developement proceeds from a single center; howver, in hypothyroidism, thyroid deficiency leads the development of multiple epiphyseal centers each with its own calcification progression. Disorderly epiphyseal calcification leads to secondary arthropathies in children with untreated congenital hypothyroidism. In the most severely affected dog,(dog 3) in this study, secondary osteoarthritis was evident in several joints.
Clinicopathological features of congenital hypothyroidism include hypercholesterolemia, hypercalcemia, and mild anemia. Hypercholesterolemia develops in both congenital and adult-onset hypothyroidsim because of decreased hepatic metabolism and decreased fecal excretion of cholesterol. Despite a reduction in cholesterol synthesis as a result of thyroid hormone deficiency, clearance of cholesterol is reduced to a greater degree than synthesis.
Hypercalcemia is mild, but usually in excess of the mild hypercalcemia associated with growth in young animals. Unlike normal growing puppies, untreated hypothyroid puppies continue to show mild increases in serum calcium during adulthood. Decreased thyroid hormone stimulation of erythropoetic precursors results in mild normocytic, normochromic anemia in some animals with hypothyroidism. Although mild decreases in erythrocytic indices (PCV, RBC count) are often observed in young animals, the puppies described in this report exhibited lower values than normal for dogs 9-12 weeks of age.
In the two dogs of this report that were most thoroughly evaluated, the results of thyroid histology, prolonged TSH testing, and repeat thyroid imaging after multiple injections of TSH were all consistent with secondary or tertiary, rather than primary, hypothyroidism. In primary hypothyroidism, histological examination of a biopsy of the thyroid gland shows loss thyroid follicles resulting from either lymphocytic thyroiditis or thyroidal atrophy. In contrast, with hypothyroidism secondary to TSH deficiency, the thyroid follicles become distended and colloid and the lining epithelial cells become flattened (as in the dogs of this report). The colloid is uniformly dense with complete or nearly complete absence of resoprtion vacuoles at the periphery of the colloid. Grossly, the thyroid glandappears normal to slightly enlarged, because of the accumulation of colloid.
With TSG stimulation testing, primary hypothyroidsim can not consistently be distinguished
from secondary or tertiary hypothyroidism using a single dose of TSH. Cases of long-standing pituitary or hypothalmic hypothyroidism with subsequent thyroid atrophy may fail to show a serum T4 response after a single dose of TSJ (like dogs with primary hypothyroidism). When TSH is administered over a period of 2-3 consecutive days, however, the serum thyroid hormone response normalizes in dogs with secondary or tertiary hypothyroidism, but remains blunted in primary hypothyroidism.
Similarly, thyroid imaging before and after prolonged TSH administration is a useful technique to aid in the differentiation between the causes of hypothyroidism. When imaged prior to the administration of TSH, the thyroid image is markedly reduced or virtually absent with either primary or secondary hypothyroidism. Administration of atrophied thyroid tissue will result in a normal thyroid image in dogs with secondary ot tertiary hypothyroidism.
Central hypothyroidism is usually associated with a number of endocrine and neurological abnormalities. Causes of central hypothyroidism include destructive or idiopathic hypothalmic lesions, and tumorous, atrophic, or idiophatic pituitary disorders. Based on clinical signs (lack of permanent or progressive neurologic deficits not attributable to the hypothyroid state) and results of pituitary function testing (adequate reserves of LH, ACTH), pituitary TSH deficiency is the most likely cause of the hypothyroidism, at least in the two dogs most thoroughly evaluated. Individuals with hypothalmic hypothyroidism should have a response to exogenous TRH that results in increased serum TSH and consequently increased serum T4 and T3 concentrations. Since the serum concentrations of T4 and T3 were unchanged in the dogs of this report, the dogs were assumed to have secondary hypothyroidism. Because the pituitary thyrotrophs remain intact with TRH deficiency, human patients with documented hypothalmic hypothyroidism have subnormal serum TSH concentrations but show normal increases in circulating TSH after administration in the dog, it will remain difficult to differentiate putuitary (secondary) from hypothalmic hypothyroidism.
In humans, isolated thyrotropin deficiency has been described in familes with a history of consanguinity, but the mode of inheritance has not been determined. The presence of several affected individuals in the same breed prompted suspicion of a genetic basis for this disorder in Giant Schnauzers. Autosomal recessive inheritance yields an expected ratio of one affected to three nonaffected individuals; however, in the case of censored data (i.e., data collected only from litters with affected individuals), this ratio is usually greater than 1:3. Litter size may also have an effect on the observed ratio of affected to nonafected individuals. Probability functions can be determined for the occurence of 1,2 or more affected individuals per litter and the probability of observing more than one affected individual per litter increases with increasing litter size. The probability of observing one affected individual in two litters of five or six, two affected in two litters of eight and two affected in one litter of 11 is approximately 0.0096. Two litters of five or six with one affected individual, one litter is 11 with two affected individuals, and one litter of eight with one affected individual were observed. The probability of observing this sample with an autosomal recessive segregating allele is 0.0082 or 85.8% as high as the highest probability. This sample, after taking into account both litter size and the censored nature of the data, is clearly consistent with the hypothesis of an autosomal recessive mode of inheritance.
It has been well established that thyroxine is essential for the proper transcription, translation and secretion of growth hormone by pituitary somatotrophs. In the two dogs tested in this study, growth hormone response to provocative stimuli (xylazine) was blunted both prior to and following thyroxine treatment. In fact, GH reserve appeared greater prior to treatment. This might be explained by the fact that the puppies were growing rapidly during the first xylazine response test; the second and third xylazine or GHRH tests were performed when the dogs were adults. In humans (and most likely the dog), circulating GH concentrations are very high during the first few days after birth but rapidly decrease during subsequent few weeks to concentrations just slightly above those in adults. However, Gh is secreted episodically, and secretory bursts can be observed in serum GH to very high values (similar to the values of noenates). If this is also the case in the dog, it may explain why the initial basal serum GH concentrations were so much higher than the follow-up adult values, but does not explain why the impaired
GH secretory capacity failed to normalize following thyroid hormone replacement therapy. Changes in growth hormone
receptors or changes in bone responsiveness (changes in somatomedin receptors) caused by GH deficiency during the period
of hypothyroidism might also explain the lack of responsiveness to GHRH or xylazine. However, in a previously reported
case of congenital hypothyroidism, the dog exhibited a blunted GH response to xylazine but had a normal GH response to
provocative stimulation following treatment of the hypothyroid state.
Related Articles
Canine Autoimmune Thyroid Disease
Behavior and Thyroid
Bizarre Behavior
Interview w/ Dr. Jean Dodds and Joanne Carson
The Immune System
Hypothyroidism
Congenital Hypothyroid Dwarfism
|